Elevation of sensitivity to anticancer agents of human lung adenocarcinoma A549 cells by knockdown of claudin-2 expression in monolayer and spheroid culture models.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Biochimica et biophysica acta. Molecular cell research

• Publication date

  2018-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bbamcr.2017.12.005PMID 29247669
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Apical cytoskeletons and junctional complexes as a combined system in epithelial cell sheets

  2017cited by this paper
• The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy

  2017cited by this paper
• Loss of E-cadherin disrupts ovarian epithelial inclusion cyst formation and collective cell movement in ovarian cancer cells

  2015cited by this paper
• Nuclear distribution of claudin-2 increases cell proliferation in human lung adenocarcinoma cells.

  2014cited by this paper
• Reduced expression of claudin-2 is associated with high histological grade and metastasis of feline mammary carcinomas.

  2014cited by this paper
• Mammosphere Formation in Breast Carcinoma Cell Lines Depends upon Expression of E-cadherin

  2013cited by this paper
• Combination of arsenic trioxide and chemotherapy in small cell lung cancer.

  2013cited by this paper
• Increase in claudin-2 expression by an EGFR/MEK/ERK/c-Fos pathway in lung adenocarcinoma A549 cells.

  2012cited by this paper
• Claudins and tricellulin in fibrolamellar hepatocellular carcinoma

  2011cited by this paper
• Claudin-2 knockdown decreases matrix metalloproteinase-9 activity and cell migration via suppression of nuclear Sp1 in A549 cells.

  2011cited by this paper
• Claudin 4 Is Differentially Expressed between Ovarian Cancer Subtypes and Plays a Role in Spheroid Formation

  2011cited by this paper
• Predicted expansion of the claudin multigene family

  2011cited by this paper
• Rapid Generation of In Vitro Multicellular Spheroids for the Study of Monoclonal Antibody Therapy

  2011cited by this paper
• Claudin-2 Expression Increases Tumorigenicity of Colon Cancer Cells: Role of Epidermal Growth Factor Receptor Activation

  2011cited by this paper
• Rac1-mediated Mitochondrial H2O2 Generation Regulates MMP-9 Gene Expression in Macrophages via Inhibition of SP-1 and AP-1*

  2010cited by this paper
• Claudin-2–deficient mice are defective in the leaky and cation-selective paracellular permeability properties of renal proximal tubules

  2010cited by this paper
• Molecular basis of the core structure of tight junctions.

  2010cited by this paper
• Is resistance useless? Multidrug resistance and collateral sensitivity.

  2009cited by this paper
• Classical resistance mechanisms.

  2009cited by this paper
• P-glycoprotein (P-gp/Abcb1), Abcc2, and Abcc3 Determine the Pharmacokinetics of Etoposide

  2009cited by this paper
• Expression of claudin-2 in the multistage process of gastric carcinogenesis.

  2008cited by this paper
• Compound profiling for ABCC2 (MRP2) using a fluorescent microplate assay system.

  2008cited by this paper
• Tight junction-based epithelial microenvironment and cell proliferation

  2008cited by this paper
• Multidrug Resistance Proteins Do Not Predict Benefit of Adjuvant Chemotherapy in Patients with Completely Resected Non–Small Cell Lung Cancer: International Adjuvant Lung Cancer Trial Biologic Program

  2007cited by this paper
• Immunohistochemical expression of MRP2 and clinical resistance to platinum-based chemotherapy in small cell lung cancer.

  2007cited by this paper
• Dynamic analysis of hepatoma spheroid formation: roles of E-cadherin and β1-integrin

  2006cited by this paper
• Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins.

  2006cited by this paper
• Multi-channel 3-D cell culture device integrated on a silicon chip for anticancer drug sensitivity test.

  2005cited by this paper
• Barriers built on claudins

  2004cited by this paper
• Signalling to and from tight junctions

  2003cited by this paper
• Expression of multidrug resistance‐associated protein 2 (MRP2) in normal human tissues and carcinomas using tissue microarrays

  2002cited by this paper
• Regulation of Expression of the Multidrug Resistance-Associated Protein 2 (MRP2) and Its Role in Drug Disposition

  2002cited by this paper
• Disruption of cell-cell adhesion enhances antibody-dependent cellular cytotoxicity: implications for antibody-based therapeutics of cancer.

  2002cited by this paper
• Induction of cPLA2 in Lung Epithelial Cells and Non-small Cell Lung Cancer Is Mediated by Sp1 and c-Jun*

  2001cited by this paper
• Multifunctional strands in tight junctions

  2001cited by this paper
• A family of drug transporters: the multidrug resistance-associated proteins.

  2000cited by this paper
• The human multidrug resistance protein 2 gene: Functional characterization of the 5′‐flanking region and expression in hepatic cells

  1999cited by this paper
• Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells.

  1999cited by this paper
• Protein Interactions at the Tight Junction

  1999cited by this paper
• Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2)

  1999cited by this paper
• Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter.

  1999cited by this paper
• Claudin-1 and -2: Novel Integral Membrane Proteins Localizing at Tight Junctions with No Sequence Similarity to Occludin

  1998cited by this paper
• Occludin: a novel integral membrane protein localizing at tight junctions

  1993cited by this paper
• Barrier function of epithelia.

  1981cited by this paper
• Oncotargets and Therapy Dovepress Combination of Gambogic Acid with Cisplatin Enhances the Antitumor Effects on Cisplatin- Resistant Lung Cancer Cells by Downregulating Mrp2 and Lrp Expression

  year unknowncited by this paper

• Claudin proteins as emerging therapeutic targets for solid tumours.

  2026cites this paper
• Cold Plasma-Activated Medium Reverses Chemoresistance in Colorectal Cancer via ROS-Mediated Suppression of ABC Transporters and Redox Homeostasis Disruption

  2026cites this paper
• Balancing act: The dual role of claudin-2 in disease.

  2025cites this paper
• Claudins proteins in brain tumors: expression patterns and therapeutic target

  2025cites this paper
• Unlocking the Potential of Spheroids in Personalized Medicine: A Systematic Review of Seeding Methodologies

  2025cites this paper
• Role of tight junction proteins in shaping the immune milieu of malignancies

  2024cites this paper
• The association of ABC proteins with multidrug resistance in cancer.

  2024cites this paper
• Reduction of Chemoresistance by Claudin‐14‐Targeting Peptide in Human Colorectal Cancer Cells

  2024cites this paper
• Downregulation of chemoresistance by claudin-14 silencing in human colorectal cancer cells.

  2024cites this paper
• Expression patterns of claudins in cancer

  2023cites this paper
• Plasma-activated medium ameliorates the chemoresistance of human lung adenocarcinoma cells mediated via downregulation of claudin-2 expression.

  2023cites this paper
• Emerging roles of transmembrane‐type tight junction proteins in cancers

  2023cites this paper
• Increase in Anticancer Drug-Induced Toxicity by Fisetin in Lung Adenocarcinoma A549 Spheroid Cells Mediated by the Reduction of Claudin-2 Expression

  2022cites this paper
• Elevation of Anticancer Drug Toxicity by Caffeine in Spheroid Model of Human Lung Adenocarcinoma A549 Cells Mediated by Reduction in Claudin-2 and Nrf2 Expression

  2022cites this paper
• The role and mechanism of claudins in cancer

  2022cites this paper
• Down-Regulation of Claudin-2 Expression by Cyanidin-3-Glucoside Enhances Sensitivity to Anticancer Drugs in the Spheroid of Human Lung Adenocarcinoma A549 Cells

  2021cites this paper
• Genomics and Prognosis Analysis of N6-Methyladenosine Regulators in Lung Adenocarcinoma

  2021cites this paper
• Biomedical Applications of Non-Small Cell Lung Cancer Spheroids

  2021cites this paper
• Aidi injection, a traditional Chinese medicine extract, reverses Gefitinib resistance in non-small cell lung cancer cells

  2021cites this paper
• Elevation of Chemosensitivity of Lung Adenocarcinoma A549 Spheroid Cells by Claudin-2 Knockdown through Activation of Glucose Transport and Inhibition of Nrf2 Signal

  2021cites this paper
• Cell subtype-dependent formation of breast tumor spheroids and their variable responses to chemotherapeutics within microfluidics-generated 3D microgels with tunable mechanics.

  2020cites this paper
• Channel functions of claudins in the organization of biological systems.

  2020cites this paper
• Kaempferide Enhances Chemosensitivity of Human Lung Adenocarcinoma A549 Cells Mediated by the Decrease in Phosphorylation of Akt and Claudin-2 Expression

  2020cites this paper
• Claudin-2 binding peptides, VPDSM and DSMKF, down-regulate claudin-2 expression and anticancer resistance in human lung adenocarcinoma A549 cells.

  2020cites this paper
• An Air Bubble-Isolating Rotating Wall Vessel Bioreactor for Improved Spheroid/Organoid Formation

  2019cites this paper
• Claudin-2: Roles beyond Permeability Functions

  2019influential citation
• Chrysin enhances anticancer drug-induced toxicity mediated by the reduction of claudin-1 and 11 expression in a spheroid culture model of lung squamous cell carcinoma cells

  2019cites this paper
• Increase in resistance to anticancer drugs involves occludin in spheroid culture model of lung adenocarcinoma A549 cells

  2018cites this paper
• Caffeic acid phenethyl ester down-regulates claudin-2 expression at the transcriptional and post-translational levels and enhances chemosensitivity to doxorubicin in lung adenocarcinoma A549 cells.

  2018cites this paper